TickerFacts.

LENZ Therapeutics, Inc. (LENZ): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

28.81M
Year ended 2025-12-31
-19.3%
3-year compound annual growth
54.87M2021-12-31: 28.92M2022-12-31: 54.87M2023-12-31: 1.96M2024-12-31: 21.28M2025-12-31: 28.81M28.81M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3128.81M+35.4%2026-03-24, From 2025-01-01
2024-12-3121.28M+986.3%2026-03-24, From 2024-01-01
2023-12-311.96M-96.4%2025-03-19, From 2023-01-01
2022-12-3154.87M+89.7%2024-02-27, From 2022-01-01
2021-12-3128.92Mn/a2023-03-20, From 2021-01-01